The European Commission has announced a forthcoming Horizon Europe Cluster 1: Health funding opportunity aimed at accelerating the development of innovative antimicrobial therapies to combat antimicrobial-resistant (AMR) bacterial and fungal pathogens.
Antimicrobial resistance remains one of the most
